A study found that one year after stopping semaglutide (generic for Ozempic) patients regained 2/3rds of their prior weight loss over the next 52 weeks
In T2D, semaglutide promotes beta cell function and insulin secretion via the incretin effect 26,27 , mechanisms that are absent in T1D
Using the efficacy estimand (treatment-adherent analysis), the 36 mg dose achieved 12.4% average weight loss, equivalent to approximately 27.3 pounds
Researchers who have completed a course of GLP-1 therapy and want to maintain some metabolic support during the transition may find resM useful as part of a broader maintenance strategy that includes proper nutrition and exercise
The difference is that with a provider guiding your care, those issues can be identified early, managed appropriately, and adjusted before they become serious problems